Nephrolithiasis and Renal Calcifications in Primary Hyperparathyroidism

被引:127
作者
Rejnmark, Lars [1 ]
Vestergaard, Peter [1 ]
Mosekilde, Leif [1 ]
机构
[1] Aarhus Univ, Dept Endocrinol & Internal Med, Aarhus Univ Hosp, DK-8000 Aarhus C, Denmark
关键词
ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; HELICAL COMPUTERIZED-TOMOGRAPHY; VITAMIN-D STATUS; BODY-MASS INDEX; KIDNEY-STONES; PARATHYROID SURGERY; NATURAL-HISTORY; RISK-FACTORS; PREVALENCE; MANAGEMENT;
D O I
10.1210/jc.2011-0569
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Renal complications in terms of hypercalciuria, nephrolithiasis, and nephrocalcinosis are well-known risks in primary hyperparathyroidism (PHPT) and may lead to impaired renal function. Evidence Acquisition: We reviewed published evidence on the occurrence, pathophysiology, and consequences of renal complications in PHPT and highlighted areas of uncertainty that should be investigated further. Evidence Synthesis: In asymptomatic PHPT, renal stones are present in approximately 7% of the patients, which is a significantly higher prevalence than among patients without PHPT(1.6%). Also, before diagnosis of PHPT, risk of hospital admissions due to renal stones is increased compared with the background population, and the risk remains increased for at least 10 yr after surgical cure from PHPT. However, shortly after parathyroidectomy, risk of recurrent stone episodes is reduced to the recurrence rate among patients with idiopathic renal stone disease. In general, patients with PHPT who develop nephrolithiasis are of younger age and more often are males, compared with those who do not form renal calcifications. Although 24-h urinary calcium is decreased after parathyroidectomy, studies have shown a higher renal calcium excretion and lower serum phosphate levels in former PHPT patients compared with healthy controls, suggesting that these patients have some additional mineral disorder. Conclusion: All patients with a diagnosis of PHPT should initially be evaluated for renal calcifications by unenhanced helical computed tomography. If calcifications are present, parathyroidectomy is recommended. If symptoms develop after parathyroidectomy, patients should be evaluated and treated similar to other patients with renal stones. (J Clin Endocrinol Metab 96: 2377-2385, 2011)
引用
收藏
页码:2377 / 2385
页数:9
相关论文
共 68 条
[31]   Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism [J].
Moosgaard, B ;
Vestergaard, P ;
Heickendorff, L ;
Melsen, F ;
Christiansen, P ;
Mosekilde, L .
CLINICAL ENDOCRINOLOGY, 2005, 63 (05) :506-513
[32]   Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function [J].
Moosgaard, B. ;
Vestergaard, P. ;
Heickendorff, L. ;
Mosekilde, L. .
CLINICAL ENDOCRINOLOGY, 2007, 66 (01) :35-42
[33]   DETERMINANTS OF PARATHORMONE SECRETION IN PRIMARY HYPERPARATHYROIDISM [J].
PAILLARD, M ;
GARDIN, JP ;
BORENSZTEIN, P ;
PRIGENT, A .
HORMONE RESEARCH, 1989, 32 (1-3) :89-92
[34]   A LACK OF UNIQUE PATHOPHYSIOLOGIC BACKGROUND FOR NEPHROLITHIASIS OF PRIMARY HYPERPARATHYROIDISM [J].
PAK, CYC ;
NICAR, MJ ;
PETERSON, R ;
ZERWEKH, JE ;
SNYDER, W .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (03) :536-542
[35]  
PAK CYC, 1979, INVEST UROL, V17, P146
[36]   ETIOLOGY AND TREATMENT OF UROLITHIASIS [J].
PAK, CYC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (06) :624-637
[37]  
Park CYC, 2008, EXPERT OPIN PHARMACO, V9, P1509, DOI [10.1517/14656566.9.9.1509 , 10.1517/14656560802150559]
[38]   Pathophysiology and management of calcium stones [J].
Park, Sangtae ;
Pearle, Margaret S. .
UROLOGIC CLINICS OF NORTH AMERICA, 2007, 34 (03) :323-+
[39]   Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism [J].
Parks, Joan H. ;
Coe, Fredric L. ;
Evan, Andrew P. ;
Worcester, Elaine M. .
BJU INTERNATIONAL, 2009, 103 (05) :670-678
[40]   RENAL MASS AND RESERVE OF VITAMIN-D - DETERMINANTS IN PRIMARY HYPERPARATHYROIDISM [J].
PATRON, P ;
GARDIN, JP ;
PAILLARD, M .
KIDNEY INTERNATIONAL, 1987, 31 (05) :1174-1180